Paradigm Capital Management, LLC/NV

Position in NVS — Novartis AG

CIK 1910312 RENO, NV

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$324,723

-$7,813 QoQ

Shares Held

2,072

-4.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#1,085

of 1,603 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Paradigm Capital Management, LLC/NV holds $8,119,187 across 5 Drug Manufacturers - General names. NVS ranks #5 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	28,084	$3,608,794
2	JNJ	Johnson & Johnson	8,100	$2,057,157
3	AMGN	Amgen Inc	4,435	$1,606,002
4	PFE	Pfizer Inc	21,699	$522,511
5	NVS	Novartis AG This page	2,072	$324,723

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$324,723	2,072	-4.8%	Shares	Sole	2026-08-14
2026-03-31	$332,536	2,177	-2.9%	Shares	Sole	2026-05-06
2025-12-31	$309,104	2,242	-1.5%	Shares	Sole	2026-02-06
2025-09-30	$291,746	2,275	-18.0%	Shares	Sole	2025-11-06
2025-06-30	$335,802	2,775	+2.8%	Shares	Sole	2025-08-14
2025-03-31	$300,996	2,700	-8.3%	Shares	Sole	2025-05-14
2024-12-31	$286,577	2,945	0.0%	Shares	Sole	2025-02-14
2024-09-30	$338,733	2,945	-12.0%	Shares	Sole	2024-11-14
2022-12-31	$303,458	3,345	-2.9%	Shares	Sole	2023-02-14
2022-09-30	$261,854	3,445	-4.8%	Shares	Sole	2022-11-14
2022-06-30	$305,998	3,620	-12.1%	Shares	Sole	2022-08-12
2022-03-31	$361,530	4,120	-5.2%	Shares	Sole	2022-05-13
2021-12-31	$380,057	4,345	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.